News1 min ago
The Rising NAFLD/NASH Epidemic Coupled with High Patient Need Offers Opportunities for Pharmaceutical Manufacturers to Capitalize Across Various Disease Stages, According to Spherix Global Insights
New Spherix research highlights existing need for innovation in this underserved population EXTON, Pa., May 22, 2023 /PRNewswire/ — The non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH)...
